Form 8-K Privia Health Group, For: Feb 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities
February 29, 2024 5:50 AM ESTTruist Securities analyst Jailendra Singh lowered the price target on Privia Health Group Inc (NASDAQ: PRVA) to $28.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "We had a post quarterly conference call with PRVA management to discuss its 4Q23 results, 2024... More
JPMorgan Positive on Privia Health Group Inc (PRVA) Following Earnings, Management Call
February 27, 2024 12:09 PM ESTJPMorgan analyst Lisa C. Gill reiterated an Overweight rating and $20.00 price target on Privia Health Group Inc (NASDAQ: PRVA)
The analyst comments "We are positive on PRVA as the companys notably more conservative and contrarian approach to capitated risk is driving greater financial... More
